
Svetlana Mojov
researcherFemale0.0Global Dominance: 0.00%
Dr. Svetlana Mojov is a researcher at Rockefeller University who contributed to the discovery of glucagon-like peptides, which have been instrumental in developing therapies for Type 2 diabetes. She is one of the co-winners of the Breakthrough Prize in Life Sciences for her significant contributions to this area of research.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Svetlana Mojov was involved in the discovery of GLP-1 related drugs.
Daniel Drucker, Canadian co-discoverer of anti-obesity drugs, among 2025 Breakthrough Prize winnersThe Globe and Mail·
Canada· 2025-04-06











